Applicant, as named in the Orange Book

Kadmon Pharms Llc

Next listed expiry: Rezurock on 14 Jul 2042. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Rezurock NDA 214783 belumosudil mesylate	belumosudil mesylate	14 Jul 2042 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.